Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
What if up to 35% of the diagnostic color data on your pathology slides never reaches your eyes—just because of your monitor? In this episode, sponsored by Barco, I sit down with Dr. Mo…
7 Counterintuitive Secrets from NCCN’s 2025 AI in Cancer Care Summit
When the National Comprehensive Cancer Network (NCCN) gathers healthcare leaders, people listen. I attended the 2025 …
What if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but chal…
What if the AI tools we trust for cancer diagnosis are not always correct? This episode of DigiPath Digest takes on the uncomfortable but critical question: can AI “lie” to us—and how d…
What if AI could predict cancer outcomes better than traditional methods—and at a fraction of the cost? In this episode, I explore how multimodal AI is reshaping lung and prostate cance…
How can pathology labs keep up with rising cancer diagnoses when the workforce is shrinking? Dr. Anil Parwani believes the answer lies in digital pathology powered by AI—and in this ep…
“AI in Pathology Isn’t Coming — It’s Already Here. Are You Ready?”
From confusion to clarity — that’s what this episode is all about. I sat down with Drs. Liron Pantanowitz, Hooman Rashi…
You think Saturday mornings are for coffee? Try diving into bone marrow morp…
AI Pathology & Genomics: A New Benchmark for Predicting Gene Mutations
If you still think visual quantification is “good enough” in pathology, think again.
In this 27th episode of DigiPa…
If our visual scoring is still based on gut feeling, how do we scale precision?
In this week’s DigiPath Digest, I explored four new AI-focused papers that could reshape how we diagnose …
If we don’t learn to work with LLMs now, we might end up competing with them. 🧠
In this week’s DigiPath Digest, I return to our Journal Club to unpack the latest research on AI in tumor…
AI in Pathology: ML-Ops and the Future of Diagnostics
What if the most advanced AI models we’re building today are doomed to die in the machine learning graveyard? 🤯 That’s the haunting …
Can We Ever Eliminate Bias in AI for Pathology?
Every time we think we’ve trained a “neutral” algorithm, we discover our own fingerprints all over it. Our biases. Unconscious. Systemic. …
The Most Overlooked Risk in AI for Pathology? It’s Not What You Think…
Welcome, my trailblazing digital pathologists! In this episode, I dive headfirst into the regulatory maze of Artifi…
In this episode sponsored by Epredia, Dr. Anil Parwani explores the transformative journey of digital pathology from basic slide scanning to AI-driven diagnostics. He shares real-world …
You might be using AI models in pathology without even knowing if they’re giving you reliable results.
Let that sink in for a second—because today, we’re fixing that.
In this episode, I …
What if I told you the biggest AI breakthroughs in pathology aren’t coming from ChatGPT or generative tools—but from the quiet power of predictive analytics and machine learning?
In this…
❗️Is synthetic data trustworthy enough to train AI for patient care? It just might be—and that's what both excites and terrifies me. ❗️
Hey trailblazers! In this episode of the Digital P…
Generative vs. Non-Generative AI in Pathology: Why the Difference Matters
If we don’t start defining what kind of AI we’re talking about, we risk letting buzzwords replace real science. …
Will FDA rules disrupt the way we diagnose diseases?
In this episode, I break down a seismic shift in lab medicine: a federal court has vacated the FDA’s controversial rule classifying …